2.1 Legal provision
Regulation D-3.2 of the International Convention for the Control and Management of
Ships' Ballast Water and Sediments, 2004, stipulates that ballast water management
systems (BWMS) that make use of Active Substances to comply with the Convention shall be
approved by the Organization. During its fifty-third session, the Marine Environment
Protection Committee (MEPC) adopted the Procedure for approval of ballast water
managemen systems that make use of Active Substances (G9) (resolution MEPC.126(53)). Resolution MEPC.169(57) revoked the initial Procedure and provided a revised
version of it.
2.2 Principles of acceptability of BWMS that make use of Active Substances
This section describes the principles of acceptability of BWMS that make use of Active
Substances, required in section 3 of Procedure (G9).
2.2.1 A ballast water management system that makes use of Active Substances accomplishes
its intended purpose through action on potentially harmful aquatic organisms and
pathogens in ships' ballast water and sediments. However, if the ballast water is still
toxic at the time of discharge into the environment, the organisms in the receiving
water may suffer unacceptable harm. Both the Active Substance itself or the Preparation,
as well as the treated ballast water, should be subjected to toxicity testing in order
to determine if an Active Substance or Preparation can be used and under which
conditions the potential for harming the receiving environment or human health is
acceptably low (G9: 3.2).
2.2.2 Any system that makes use of, or generates, Active Substances, Relevant Chemicals
or free radicals during the treatment process to eliminate harmful organisms and
pathogens in order to comply with the Convention should be subject to Procedure (G9)
(G9: 3.3).
2.2.3 Ballast water management systems that make use of Active Substances and
Preparations must be safe in terms of the ship, its equipment and the personnel to
comply with the Convention (G9: 3.4).
2.2.4 The Administration should determine if a BWMS that uses UV irradiation produces
Active Substances and decide whether it needs to make a proposal for approval to the
Committee or not (MEPC 59/24, paragraph 2.17).
2.3 Submission of an application for approval
This section describes the procedure to submit an application for approval specified in
sections 8.1 and 8.2 of Procedure (G9).
2.3.1 The manufacturer should evaluate the system, the Active Substances or Preparations
and the potential discharge in accordance with the approval criteria specified in the
Procedure for approval of ballast water management systems that make use of Active
Substances G9).
2.3.2 Upon completion of the evaluation the manufacturer should prepare an application
on the system that makes use of Active Substances or Preparations and submit it to the
Member of the Organization concerned. An application should only be made when the
ballast water management system using Active Substance or Preparations has been
sufficiently designed, developed and tested to provide the full data necessary for Basic
or Final Approval as appropriate (G9: 8.1.2.2).
2.3.3 For systems that have previously received Basic Approval, the provisions of the
Framework for determining when a Basic Approval granted to one BWMS may be applied
to another system that uses the same Active Substance or Preparation should apply
(BWM.2/Circ.27).
2.3.4 Upon receipt of an application, the concerned Administration should conduct a
careful completeness check to ensure that the application satisfies all the provisions
contained in Procedure (G9) and that it is presented in the format recommended in this
Methodology. Administrations should check the quality and completeness of any
application against the latest version of the Methodology for information gathering and
conduct of work of the GESAMP-BWWG, agreed by the Organization, prior to its submission
to the MEPC. For Final Approval applications, the Administration should ensure that all
the recommendations given by the GESAMP-BWWG during the Basic Approval process have been
addressed to its complete satisfaction.
2.3.5 When the Administration is satisfied with the application received in accordance
with paragraph 3.6 of Procedure (G9), it should submit a proposal for approval to the
rganization consisting of the following:
-
.1 a description of the ballast water management system containing the
non-confidential data in the usual format for dissemination as an MEPC document
(preferably less than 50 pages). Administrations should aim at submitting the
non-confidential descriptions of their ballast water management systems at the
MEPC session, which precedes the MEPC session expected to decide on the approval
of the systems. If this is not possible, the non-confidential description should
be submitted at the earliest opportunity to the MEPC session expected to decide on
the approval of the systems, but not later than the 28-week deadline established
as indicated in paragraph 2.3.7 below. Documents containing non-confidential
descriptions of BWMS, which contain more than 20 pages, will not be translated
into all working languages in their entirety. They should include, for translation
purposes, a summary of the document not longer than four pages, with the technical
content submitted as an annex in the language (e.g. English) that may be needed,
for example, by working groups. Proponents seeking approval of BWMS that use
Active Substances should thoroughly observe the provisions of paragraph 8.1.1 of
Procedure (G9), bearing in mind that failure to provide the non-confidential
information could result in Member States having insufficient data to approve the
proposals when requested by the Committee. INF documents could be used in
conjunction with proposals for approval to ensure that all safety and
environmental protection data are made available;
-
.2 a Letter of Agreement concerning the arrangements between IMO and the
submitting Administrations for the evaluation of the respective system. A template
of such a letter is provided in appendix 1;
-
.3 the complete application dossier in accordance with Procedure (G9) consisting
of the full description of the system, tests results, study reports, references
and copies of the literature referenced and any other information relevant to that
system. A summary of the key data should be provided in a tabular format. The
complete application dossier should contain a list of contents indicating the
location of the information in the application. Pursuant to paragraphs 4.2.2,
8.1.1 and 8.1.2.7 of Procedure (G9), the information mentioned above will be
treated as confidential. It should be noted, however, that all information related
to safety and environmental protection, including physical/chemical properties,
environmental fate and toxicity, will be treated as non-confidential; and .4 the
assessment report in accordance with paragraph 4.3 of Procedure (G9).
2.3.6 Proposals for approval of ballast water management systems that make use of Active
Substances that need to be evaluated by the GESAMP-BWWG should be addressed to:
- Marine Environment Division
- International Maritime Organization
- 4 Albert Embankment
- London SE1 7SR
- United Kingdom
2.3.7 A non-refundable registration fee to cover the costs related to the services
provided by the GESAMP-BWWG should be paid upon receipt of the invoice issued by the
Organization in this respect. It should be noted that the evaluation of a proposal for
approval cannot be initiated before the payment of the fee mentioned above.
2.3.8 The GESAMP-BWWG aims to hold its meetings 20 weeks before the MEPC session
expected to decide on the approval of the proposals made by the Member Governments.
Consequently, a 28-week deadline has been established for the submission of the proposal
for approval (including the complete application dossier). This allows eight weeks for
the preparation of the meeting and enables interested parties to provide information
that is relevant to the evaluation in accordance with the provisions of paragraph
8.1.2.6 of Procedure (G9). A timetable used for planning the activities related to the
GESAMP-BWWG meetings is shown in appendix 2.
2.3.9 When due to the time constraints the GESAMP-BWWG is not able to evaluate all the
proposals for approval submitted before the deadline established as indicated in
paragraph 2.3.8 above, an extraordinary meeting of the GESAMP-BWWG may be convened,
subject to the availability of the Group and with the authorization of the
Secretary-General of the Organization.
2.3.10 The GESAMP-BWWG will endeavour to evaluate as many proposals for approval as
possible received before the deadline described in paragraph 2.3.8 above. When due to
the time limitations between two consecutive sessions of the MEPC, the GESAMP-BWWG is
not able to evaluate all the proposals for approval received before the above deadline,
the remaining proposals will be evaluated on a "priority basis", in accordance with the
order of submission during the subsequent meetings of the GESAMP-BWWG. Proposals for
approval received after the established deadline will be referred to the MEPC session
following the session used to establish the deadline and will be considered after any
priority proposals not considered at previous meetings.
2.3.11 Upon receipt of a complete proposal for approval, the Organization will issue a
confirmation letter indicating the date and the time the proposal has been received. In
order to ensure complete transparency and a fair and impartial treatment of all the
submissions, the proposals for approval are evaluated in the chronological order of
their receipt.
2.3.12 Face-to-face meetings between the GESAMP-BWWG and applicants/Administrations
should be conducted at the request of the Administrations prior to the meeting and
solely during Final Approval evaluations. Face-to-face meeting should be limited to one
hour per Final Approval application.
2.3.13 Clarification of certain aspects identified during the preparation for, or in the
process of, an evaluation of a proposal for approval may be requested by the
GESAMP-BWWG, if it becomes evident that clarification is found to be necessary in order
to finalize the evaluation. The clarifications should be received in a timely manner so
that the GESAMP-BWWG is able to take the information into account during its evaluation
of the system. A time limit for response to any request for clarifications should not
exceed 24 hours unless otherwise agreed with the GESAMP-BWWG. Applicants may wish to
designate a technical representative to provide clarifications on request during the
Group's meeting.
2.3.14 After completion of the GESAMP-BWWG report, relevant annexes containing the
results of the evaluation will be forwarded to the respective Administrations for
confirmation that no confidential data are being disclosed. Unless the Administration
advises otherwise before the deadline indicated in the request for confirmation
(normally one week), the Secretariat will assume that the respective evaluation does not
contain confidential data and will process the report according to the timetable shown
in appendix 2.
2.3.15 If after the revision of the draft report of the GESAMP-BWWG the GESAMP provides
comments on the findings of the Group, the Chair of the GESAMP-BWWG, in consultation
with the members of the Group, as appropriate, will address the respective comments. The
GESAMP provides confirmation of peer review and approval to the Organization for the
information of the MEPC.
2.3.16 In case an Administration that has submitted a proposal for approval disagrees
with the recommendations of the GESAMP-BWWG, such an Administration should be given the
option to submit a document indicating the reasons for disagreement to the session of
the MEPC expected to decide on the respective proposal. The explanatory document should
be considered by the Committee in conjunction with the GESAMP-BWWG report.
2.3.17 Any supplementary data regarding a proposal not recommended for approval that was
provided to the GESAMP-BWWG after the completion of its meeting will be considered as a
new proposal, subject to a new deadline for evaluation according to the procedure
described in this Methodology and subject to a new registration fee.
2.3.18 The Secretariat will endeavour to forward all the requests for clarification
regarding the published reports of the GESAMP-BWWG received from the Administrations
concerned to the Chairman of the GESAMP-BWWG and to the IMO consultant responsible for
the respective meeting for response as appropriate.
2.4 Confidentiality and data protection
This section describes the confidentiality and data protection specified in paragraphs
8.1.1 and 8.1.2.7 of Procedure (G9).
The confidential information in the submitted documents should be clearly identified.
All information related to safety and environmental protection, including
physical/chemical properties, environmental fate and toxicity, will be treated as
non-confidential with the understanding that original proprietary test reports and
studies, with the exception of the summary of the results and test conditions to be
prepared by the applicant and validated by the GESAMP-BWWG, are considered confidential
(G9: 8.1.1). Once an approval procedure is completed and the system using the Active
Substance is approved, the following data should not be regarded as confidential:
-
.1 the name and address of the Administration;
-
.2 the names and addresses of the Administrations of the Active Substance and/or
the Preparation (if different);
-
.3 the names and amount of the Active Substance(s) in the Preparations and the
name of the Preparation;
-
.4 the names of other components of Preparations, in particular those that are
regarded as dangerous according to the UN GHS or relevant IMO regulations and
contribute to the hazard documentation of the Preparation;
-
.5 the names of Relevant Chemicals that may be formed during or after application
of the BWMS and that may be of concern for the receiving environment or human
health;
-
.6 methods of chemical analysis, including the Limit of Detection (LOD);
-
.7 physical and chemical data concerning the Active Substance, the Preparation and
its components and Relevant Chemicals;
-
.8 a summary of the results of the tests conducted pursuant to section 4.2 of the
Procedure (G9) to establish the effects of the substance(s) or Preparation(s) on
humans and the environment;
-
.9 a summary of the results of the tests conducted on the treated ballast water
pursuant to section 5.2 of Procedure (G9);
-
.10 recommended methods and precautions against dangers resulting from handling,
storage, transport and fire;
-
.11 any means of rendering the Active Substance or Preparation harmless;
-
.12 methods of disposal of the product and of its packaging;
-
.13 procedures to be followed and measures to be taken in the case of spillage or
leakage;
-
.14 first aid and medical advice to be given in the case of injury to persons;
-
.15 Safety Data Sheets, which should contain the information required of items .7
to .14;
-
.16 all results of the Persistence, Bioaccumulation and Toxicity (PBT) assessment
and the risk characterization pursuant to sections 5.1 and 5.3 of Procedure (G9);
and
-
.17 the uncertainty analysis specified in paragraph 6.4.3 of Procedure (G9).
2.5 Test methods
This section describes the test methods specified in paragraphs 4.2.3 to 4.2.4 of
Procedure (G9).
2.5.1 Tests, which are described in 3.3.2, 3.3.3 and 6.1.3., should be carried out under
internationally recognized guidelines (preferably OECD or equivalent) (G9: 4.2.3), and
according to an internationally recognized quality assurance system (G9: 4.2.4) (e.g.
Good Laboratory Practice (GLP)). Information may be derived from existing data where an
acceptable justification is provided. Full copies of sources of data (e.g. literature
papers) and relevant documents for QA/QC (i.e. QAPP) should be provided electronically
and in hard copy. The relevant document should include validity criteria for all
tests.
2.5.2 Care should be taken to provide full supporting references and copies of the
appropriate test laboratory reports in support of each application electronically and in
hard copy. If submissions are lacking relevant information, it may not be possible for
the GESAMP-BWWG to conduct its risk assessment.
2.5.3 Many substances have acquired large databases for many of the hazards concerned
and a weight of evidence approach has become necessary to ensure that the rating
reflects the body of data rather than simply using the most conservative value. This,
however, means that the submission of all available end-point data for Active Substances
and Relevant Chemicals is necessary to enable a review.
2.6 Alternatives to testing and non-submission of data
2.6.1 Alternative methods to testing on live organisms, e.g. in vitro testing methods,
Quantitative Structure-Activity Relationship (QSAR), extrapolation by analogy to known
chemicals, or grouping of similar substances, may be used whenever justified. Sufficient
documentation or references to documentation on the validity of the method should be
provided, as well as documentation that the substance or Preparation lies within the
applicability domain of the method.
2.6.2 Information that is not necessary, owing to the nature of the substance, need not
be supplied. The same applies where it is not scientifically justified or technically
feasible to supply the information. In such cases, a justification for not supplying
such information should be submitted.
2.7 Additional data
2.7.1 If, in the course of the review by the GESAMP-BWWG, the Group considers that
additional data are found to be necessary to finalize the evaluation, the Group may, in
exceptional circumstances, request that such data are provided to facilitate the
review.
2.7.2 The applicant should not submit any additional data after the dossier has been
submitted to the Organization for evaluation unless such data have been requested by the
Group.
2.8 Retrospective requirement
Once a ballast water management system has received Final Approval under this procedure,
then the respective applicant should not have to retrospectively submit new data in
accordance with this revised Methodology (paragraph 8.2.3 of Procedure (G9)).